(Q46500039)

22 December 2017

title

Pediatric inflammatory bowel disease: what children can teach adults (English)

1 reference

22 December 2017

inflammatory bowel diseases

main subject

inflammation

0 references

1 reference

Elizabeth Hait

1

1 reference

22 December 2017

Athos Bousvaros

series ordinal

2

1 reference

22 December 2017

Richard Grand

series ordinal

3

1 reference

22 December 2017

publication date

1 June 2005

1 reference

22 December 2017

Inflammatory Bowel Diseases

published in

1 reference

22 December 2017

volume

11

1 reference

22 December 2017

page(s)

519-527

1 reference

22 December 2017

issue

6

1 reference

22 December 2017

Epidemiologic and clinical characteristics of children with newly diagnosed inflammatory bowel disease in wisconsin: a statewide population-based study

cites work

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000166932.66853.FD

The epidemiology of paediatric inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000166932.66853.FD

Changing pattern of paediatric inflammatory bowel disease in northern Stockholm 1990-2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000166932.66853.FD

Incidence of inflammatory bowel disease in Scottish children between 1968 and 1983; marginal fall in ulcerative colitis, three-fold rise in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000166932.66853.FD

Epidemiology of inflammatory bowel disease: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000166932.66853.FD

Colitis complicating chronic granulomatous disease. A clinicopathological case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000166932.66853.FD

Impaired glucose homeostasis, neutrophil trafficking and function in mice lacking the glucose-6-phosphate transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000166932.66853.FD

Lytic granules, secretory lysosomes and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000166932.66853.FD

The Wiskott-Aldrich syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000166932.66853.FD

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000166932.66853.FD

Neutrophil adherence receptor deficiency regressing with granulocyte-colony stimulating factor therapy in a case of glycogen storage disease type Ib.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000166932.66853.FD

Pediatric patients with untreated ulcerative colitis may present initially with unusual morphologic findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000166932.66853.FD

Histopathology of ulcerative colitis in initial rectal biopsy in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000166932.66853.FD

Focally enhanced gastritis in children with Crohn's disease and ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000166932.66853.FD

Thiopurine drugs in the treatment of childhood leukaemia: the influence of inherited thiopurine methyltransferase activity on drug metabolism and cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000166932.66853.FD

6-Mercaptopurine metabolism in Crohn's disease: correlation with efficacy and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000166932.66853.FD

Utilisation of erythrocyte 6-thioguanine metabolite levels to optimise azathioprine therapy in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000166932.66853.FD

Thiopurine methyltransferase activity influences clinical response to azathioprine in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000166932.66853.FD

Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000166932.66853.FD

A controlled double blind study of azathioprine in the management of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000166932.66853.FD

Use of 6-mercaptopurine/azathioprine as the immunomodulator of choice for moderately active Crohn's disease: pro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000166932.66853.FD

Use of 6-mercapturine/azathioprine as the immunomodulator of choice for moderately active Crohn's disease: con.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000166932.66853.FD

Use of 6-mercaptopurine/azathioprine as the immunomodulator of choice for moderately active Crohn's disease: balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000166932.66853.FD

Long term prognosis of Crohn's disease with onset in childhood and adolescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000166932.66853.FD

Serum concentrations of tumour necrosis factor alpha in childhood chronic inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000166932.66853.FD

Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000166932.66853.FD

Tumor necrosis factor-alpha inhibits growth hormone secretion from cultured anterior pituitary cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000166932.66853.FD

Inflammatory bowel disease and predisposition to osteopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000166932.66853.FD

Risk factors for low bone mineral density in children and young adults with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000166932.66853.FD

Increased rate of spinal trabecular bone loss in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000166932.66853.FD

A four-year longitudinal study of bone loss in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000166932.66853.FD

Bone loss in patients with inflammatory bowel disease: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000166932.66853.FD

Bone mineral acquisition in healthy Asian, Hispanic, black, and Caucasian youth: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000166932.66853.FD

Bone mineral acquisition during adolescence and early adulthood: a study in 574 healthy females 10-24 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000166932.66853.FD

Bone gain in young adult women

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000166932.66853.FD

Peak bone mass in young women

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000166932.66853.FD

10.1097/01.MIB.0000166932.66853.FD

21 January 2018

Identifiers

DOI

1 reference

22 December 2017

PubMed ID

15905698

1 reference

22 December 2017